Mar 25th, 2026
FDA Warning Letter to a Global Specialty Pharma Company: Critical Pharmacovigilance Compliance Lessons
Key lessons from an FDA warning letter to a global specialty pharma company on signal detection and reporting.
Mar 17th, 2026
FDA Launches Unified Adverse Event Monitoring System (AEMS) to Modernize Safety Surveillance
How the new AEMS modernizes safety surveillance and what it means for pharmacovigilance teams.
Nov 20th, 2024
AI Adoption: A Simple Framework for Risk Management
With Artificial Intelligence (AI) in general, and Generative AI in particular becoming the next big thing in technology, we see…
Oct 28th, 2024
Presentation: AI in Drug Safety Operations – The Future is Here!
Narasimha Kumar, Chief Product Officer at Datafoundry, delivered an engaging presentation titled “AI in Drug […]
Mar 18th, 2024
AI can revolutionize Multi-vigilance for Enhanced Patient Safety
The healthcare landscape is a dynamic ecosystem, constantly growing with new drugs, cosmetics, nutraceuticals, and […]
Feb 15th, 2024
Use of AI in Pharmacovigilance Automation
In the past few years, the domain of Pharmacovigilance (PV) (incl. Cosmetovigilance and Materiovigilance) […]
Jan 16th, 2024
The need for a Safety Vigilance BPaaS Model
The challenges of Safety Vigilance in Pharma, Cosmetics, Devices, Vaccines and Nutraceuticals are creating a […]
Dec 15th, 2023
Understanding and Harnessing the Exponential Growth of Life Sciences Data
Navigating the Tsunami of Data According to a recent report by Arcadia Approximately 30% of […]
Oct 26th, 2023
Unlocking the Potential of Drug Safety Automation for Small and Medium Pharma: People, Process, and System
The pharmaceutical industry is advancing at an unprecedented pace, with new drugs and therapies continually emerging to improve patient outcomes.…